Ambit Biosciences Announces Second Quarter 2013 Operational Results

Published: Aug 14, 2013

Regeneron may be hiring! Check it out! (Isn't it tempting?)

SAN DIEGO, Aug. 13, 2013 /PRNewswire/ -- Ambit Biosciences (NASDAQ: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced results for the second quarter and six months ended June 30, 2013. The company will host a conference call today to provide an operational update and discuss financial results, its first as a public company.

Help employers find you! Check out all the jobs and post your resume.

Back to news